Safety and efficacy of encorafenib–cetuximab combination in BRAF-mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study

Safety and efficacy of encorafenib–cetuximab combination in BRAF-mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study

Saved in:
Bibliographic Details
Published in:ESMO Real World Data and Digital Oncology Vol. 5; p. 100055
Main Authors: Fernández-Montes, A., Ros, J., García-Alfonso, P., Graña, B., Brozos-Vázquez, E., Melián, M., Jiménez-Gordo, A.Mª, Martínez de Castro, E., Busquier, I., Ferrández Arias, A., Grávalos, C., Covela, M., Ruíz-Casado, A., González-Flores, E., Safont, Mª J., Cano, J.Mª, Alonso-López, C., Gómez-Reina, Mª J., Donnay, O., Manzano-Mozo, J.L., Sampedro Domarco, P., Falcó, E., Rodríguez, N., García-Benito, C., Aranda, E.
Format: Journal Article
Language:English
Published: 01-09-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2949-8201
2949-8201
DOI:10.1016/j.esmorw.2024.100055